An aberrant variant of secretin receptor (encoded by the SCTR gene) was found, where the third exon is spliced out and therefore residues 44–79 from the NH [2]-terminal tail are eliminated, blocking secretin binding, and thus prompting tumor growth and progression [94, 95]. The gene discussed is SCTR; the disease is neoplasm.